---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-050569"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T04:29:13.241197+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Chemours Q1 earnings: net sales $1.35B (-12% YoY), net income $52M, adj EBITDA $193M

## Summary
- Net sales $1.35B, down 12% YoY; volumes -6%, price -5%.
- Net income attributable to Chemours $52M ($0.34 per diluted share) vs $145M ($0.96) in Q1 2023.
- Adjusted EBITDA $193M vs $304M (-37%).
- Cash flows used in operations -$290M; capex $102M; dividends $37M.
- Segment declines: APM -23%, TT -7%, TSS -8%.

## SEC filing metadata
- accession: 0000950170-24-050569
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/0000950170-24-050569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/cc-20240430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-050569
- JSON: https://secwatch.observer/filing/0000950170-24-050569.json
- Plain text: https://secwatch.observer/filing/0000950170-24-050569.txt

## Key facts
- Earnings Releases
  Chemours Co reported first quarter 2024 results: revenue $1.4 billion, net income $52 million, or $0.34 per diluted share, EPS $0.34 per diluted share.
  - Period: first quarter 2024
  - Revenue: $1.4 billion
  - Net income: $52 million, or $0.34 per diluted share
  - EPS: $0.34 per diluted share
  - Result: reported results
  source text: Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2024. Key First Quarter 2024 Results • Net Sales of $1.4 billion, down 12% year-over-year • Net Income attributable to Chemours of $52 million, or $0.34 per diluted share, compared with $145 million, or $0.96 per diluted share, in the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/0000950170-24-050569-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.